Patent details
93382
Product Name:
"Combinaison de rilpivirine ou une forme thérapeutique équivalente qui en dérive telle que protégée par le brevet de base, tel qu'un sel pharmaceutiquement acceptable de rilpivirine, incluant le sel chlorhydrate de rilpivirine et ténofovir alafénamide, ou un sel pharmaceutiquement acceptable de celui-ci, en particulier le fumarate de ténofovir alafénamide"
Basic Information
- Publication number:
- 93382
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
-
EP047870969
- Legal Status:
- Active
- Application number:
- 93382
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/16/1112 Odefsey - emtricitabine
- Marketing Authorization Type:
-
- Marketing Authorization Date:
- 23/06/2016
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
-
Dates
- Filing date:
- 20/12/2016
- First Marketing Authorization date:
- 23/06/2016
- Grant date:
- 17/03/2017
- Activation date:
- 03/09/2024
- Publication date:
- 17/03/2017
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 03/09/2029
- SPC Extension Expiration:
- 03/09/2029
- Rejection date:
- Withdrawal date:
Owner
- From:
- 20/12/2016
-
-
- Name:
- Janssen Sciences Ireland UC
- Address:
- Eastgate Village, Eastgate, Little Island, County Cork, Ireland (IE)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 20/12/2016
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
- Name:
- STOFFELS Paul
- Address:
- Belgium (BE)
Publication
Bulletin
1
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2017/02
- Publication date:
- 22/06/2017
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
2
- Bulletin Heading:
- SPC3
- Bulletin edition number:
- 2025/04
- Publication date:
- 04/03/2025
- Description:
- Section E : Supplementary Protection certificates entered into force – IA publication
Annual Fees
- Annual Fee Due Date:
- 30/09/2025
- Annual Fee Number:
- 22
- Annual Fee Amount:
- 420 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 29/08/2024
- Last Annual Fee Paid Number:
- 21
- Last Annual Fee Paid Amount:
- 410 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM